McKesson Corporation vs Quantumscape Corp — how do they compare? McKesson Corporation trades at $895 (market cap $105.14B), while Quantumscape Corp trades at $6.38 (market cap $3.90B). The key difference: McKesson Corporation is far larger — about 27× Quantumscape Corp's market cap, and McKesson Corporation pays a 0.42% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals.
| MCK | QS | |
|---|---|---|
Market Cap | $105.14B | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $995.69 | $18.44 |
52-Week Low | $659.01 | $4.89 |
Enterprise Value | $111.67B | $3.11B |
Dividend Yield | 0.42% | — |
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →